Ophthalmic and Topical Dosage Form New Animal Drugs; Selamectin
other · Food and Drug Administration · Rule · Published 2009-04-30 · Effective 2009-04-30 · 74 FR 19877
Document
Document number
E9-9901
Federal Register citation
74 FR 19877
CFR reference
21 CFR 524
Type
Rule
Action
Final rule.
Category
other
Sub-agency
Food and Drug Administration
Publication date
2009-04-30
Effective date
2009-04-30
HHS docket
Docket No. FDA-2009-N-0665
Abstract
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Pfizer, Inc. The supplemental NADA revises the minimum age of treatment from 6 weeks to 8 weeks for kittens treated with a topical selamectin solution.